Itron, Inc. (NASDAQ:ITRI)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research report issued to clients and investors on Friday. They currently have a $84.00 target price on the scientific and technical instruments company’s stock. Needham & Company LLC’s price objective would indicate a potential upside of 21.07% from the company’s current price.

Several other analysts have also recently issued reports on ITRI. Zacks Investment Research cut shares of Itron from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. BidaskClub raised shares of Itron from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, July 12th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $78.00 price target (up previously from $75.00) on shares of Itron in a research note on Friday, August 4th. Robert W. Baird reissued a “hold” rating and issued a $77.00 price target on shares of Itron in a research note on Tuesday, September 12th. Finally, Cowen and Company set a $74.00 price target on shares of Itron and gave the company a “hold” rating in a research note on Thursday, August 3rd. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $81.78.

Shares of Itron (NASDAQ:ITRI) traded down $8.92 during midday trading on Friday, reaching $69.38. 345,853 shares of the company traded hands, compared to its average volume of 200,950. The company has a market cap of $2.58 billion, a PE ratio of 24.37, a PEG ratio of 1.07 and a beta of 1.07. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.18 and a current ratio of 1.67.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Wednesday, November 1st. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.12). Itron had a net margin of 3.42% and a return on equity of 14.84%. The business had revenue of $486.75 million for the quarter, compared to analysts’ expectations of $526.55 million. During the same period in the prior year, the company posted $0.77 EPS. The firm’s revenue was down 4.0% on a year-over-year basis. analysts predict that Itron will post 2.97 EPS for the current year.

WARNING: “Needham & Company LLC Reiterates Buy Rating for Itron, Inc. (ITRI)” was originally published by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/11/03/needham-company-llc-reiterates-buy-rating-for-itron-inc-itri.html.

Several hedge funds have recently modified their holdings of ITRI. PNC Financial Services Group Inc. lifted its holdings in shares of Itron by 2.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,610 shares of the scientific and technical instruments company’s stock worth $109,000 after acquiring an additional 31 shares during the last quarter. Pacad Investment Ltd. lifted its holdings in shares of Itron by 21.4% in the 2nd quarter. Pacad Investment Ltd. now owns 1,700 shares of the scientific and technical instruments company’s stock worth $115,000 after acquiring an additional 300 shares during the last quarter. Riverhead Capital Management LLC lifted its holdings in shares of Itron by 74.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,097 shares of the scientific and technical instruments company’s stock worth $142,000 after acquiring an additional 897 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of Itron by 1.5% in the 1st quarter. SG Americas Securities LLC now owns 2,366 shares of the scientific and technical instruments company’s stock worth $144,000 after acquiring an additional 36 shares during the last quarter. Finally, Royal Bank of Canada lifted its holdings in shares of Itron by 10.9% in the 2nd quarter. Royal Bank of Canada now owns 3,042 shares of the scientific and technical instruments company’s stock worth $206,000 after acquiring an additional 299 shares during the last quarter. Hedge funds and other institutional investors own 93.49% of the company’s stock.

Itron Company Profile

Itron, Inc (Itron) is a technology and service company. The Company provides solutions that measure, manage and analyze energy and water use. The Company operates through three segments: Electricity, Gas and Water. It provides a portfolio of products, solutions, software and services to electric, gas and water utility customers across the globe.

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron Inc. and related companies with MarketBeat.com's FREE daily email newsletter.